portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Hepalink Pharmaceutical: profit declined in 2011H1, influenced by export price shrink of heparin APIs
 
CreateTime:2011-09-19     Source:ResearchInChina Editor:hangmei
Text Size:       
 

Operating revenue of Hepalink Pharmaceutical reached RMB1.57 billion in 2011H1, a decline of 13% YoY; meanwhile, its operating profit achieved RMB420 million, down 40.3% YoY. The main reason for the decline was price shrink of heparin APIs which was the main product of Hepalink. 

China is abundant with resources of heparin raw material, and is the largest heparin APIs producing country in the world. Hepalink is one of the most important manufacturers and exporters of heparin APIs in China. Its export proportion reached 99.4%, 97.2%, 96.5% and 87.7% in 2008, 2009, 2010, and 2011H1 respectively. During Jan. to Jul. 2011, market demand of heparin maintained steadily while the supply was relatively abundant in China, which caused export competition intensifying. The export average price fell to USD9, 061/kg, down 11.5% YoY, which further influenced Hepalink’s performance in 2011H1. However, supply and demand gap of swine is increasingly huge, and price of swine small intestine for heparin API is expected to be recovered, which further drives price rose of heparin sodium API, thus operating revenue of Hepalink is hoped to increase in 2011H2. 

Export Price Trend of Heparin Products in China, 2008-Jul. 2011 (USD/kg)

Source: China Customs; ResearchInChina


Related Reports
China Blood Product Industry Report, 2014-2017
China Animal Vaccine Industry Report, 2013-2016
China Contract Research Organization (CRO) Industry Report, 20...
Global and China Biodegradable Plastics Industry Report, 2013-...
Global and China Industrial Enzyme Industry Report, 2014-2016
2005-2010 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1